BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3
Clinical trial NCT01830127 · COMPLETED
Trial details
- NCT number
- NCT01830127
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.